- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
环磷腺苷葡胺在体外循环中对心肌的保护作用
来源:广东省医药卫生信息网?点击数:254?更新时间:2008-9-8?文章录入:yjhan
????
【摘要】? 目的 通过观察体外循环(extracorporeal circulation,ECC)中使用环磷腺苷葡胺心肌停博液对围术期心肌酶学、病理学及临床的影响,探讨其在ECC术中的心肌保护作用。方法 选择48例单纯二尖瓣置换手术的患者,随机分为实验组(n=24)和对照组(n=24)。实验组在首次灌注液中加入环磷腺苷葡胺180 mg,对照组沿用4℃的4∶1含血停搏液。分别于ECC前、开放升主动脉后30 min、术后6 h、24 h、48 h共五个时点采集动脉血,检测肌酸激酶同工酶(CKMB)、乳酸脱氢酶(LDH)和心肌肌钙蛋白I(cTnI)。观察围术期临床指标及心肌病理变化。结果 两组患者术后CKMB、LDH和cTnI有显著差异(P0.05)。临床指标及心肌病理变化均支持实验组优于对照组。结论 在心脏停博液中加入环磷腺苷葡胺可在ECC中起到一定的心肌保护作用。
【关键词】? 环磷腺苷葡胺 体外循环 心肌保护
??? Myocardial Protective Effect of Meglumine Adenosine
??? Cyclophosphate during Extracorporeal Circulation
??? WU Yong1,LIU Gong-jian2
??? ( 1.Department of Anaesthesiology,The Lianyungang Affiliated Hosipital of Xuzhou Medical College,
??? Jiangsu Lianyungang 222002;2.Department of Anaesthesiology,
??? The Affiliated Hosipital of Xuzhou Medical College,Jiangsu Xuzhou 221002,China)
??? Abstract: OBJECTIVE?? By measurig the changes of myocardial enzyme and pathology to investigate the clinical effect of meglumine adenosine cyclophosphate injection during extracorporeal circulation(ECC). METHODS? Fourty eight patients scheduled for mitral valve replacement surgery were randomly divided into two groups.Meglumine adenosine cyclophosphate injection (180mg) was added into the prime perfusate during ECC in treated group(n=24) ,but not in control group(n=24). The changes of myocardial pathology and clinical index were observed.Blood samples were drawn from the artery at the following time points:before ECC,30 min after aortic clamping,6h ,24h and 48h after aortic declamping. Enzyme-linked immunosorbent assays were used to measure the levels of CKMB,LDH and cTnI in plasma.RESULTS? The levels of CKMB,LDH and cTnI in two groups showed significantly difference after ECC(P0.05). The changes of myocardial pathology and clinical index in treated group surpassed that in control group. CONCLUSION? Meglumine adenosine cyclophosphate injection can protect myoeardium after ECC.
??? Key words:? Meglumine a
原创力文档


文档评论(0)